Tuatara® Diagnostics is developing its own range of products, which are currently brought to market through partners acting as legal manufacturers and with plans to introduce them under our own brand in the future. These products are built on our innovative technology platform, which enables rapid and accurate detection, and differentiation, of target RNA and DNA.

Our assays are based on both qPCR and isothermal amplification techniques and are designed for use on open laboratory platforms as well as integration into point-of-care (POC) devices. Tuatara® is active in the veterinary market and, together with a partner, develops various products for the farming industry.

To support future integration of our proprietary molecular detection technologies, we are developing a point-of-care cartridge platform designed to accommodate multiple diagnostic tests.

Our products stand for reliable sample-to-result workflows for a variety of specimen types, with easy-to-read outputs. We design high-quality, robust tests that are validated according to strict regulatory standards, with a focus on user-friendliness, while combining cost-effectiveness and flexibility, for use in the lab, at the bedside, or directly in the field.